Smartest Doc
Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma
International Journal of Clinical Oncology, 05/01/2012
Clinical Article
He A et al. – Pirarubicin–based chemotherapy was comparable with gemcitabine–docetaxel as a second–line treatment for relapsed and refractory osteosarcoma, and it even seemed to show greater efficacy, with milder toxicity.